Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Many fluid biomarker findings have had low reproducibility despite initially promising results. Here, the authors review possible sources for low reproducibility of studies on fluid biomarkers for neurodegenerative diseases and suggest guidelines for the biomarker community to agree on and implement...
Guardado en:
Autores principales: | Niklas Mattsson-Carlgren, Sebastian Palmqvist, Kaj Blennow, Oskar Hansson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f9ad7fe719b463fa1f77344a46120a2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
por: Niklas Mattsson-Carlgren, et al.
Publicado: (2021) -
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
por: Niklas Mattsson, et al.
Publicado: (2016) -
Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
por: Sebastian Palmqvist, et al.
Publicado: (2012) -
Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
por: Lovisa Tobieson, et al.
Publicado: (2021) -
Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer’s disease
por: Atul Kumar, et al.
Publicado: (2021)